Emotional expressions of the sick face.


Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
08 2019
Historique:
received: 27 11 2018
revised: 11 03 2019
accepted: 02 04 2019
pubmed: 7 4 2019
medline: 22 5 2020
entrez: 7 4 2019
Statut: ppublish

Résumé

To handle the substantial threat posed by infectious diseases, behaviors that promote avoidance of contagion are crucial. Based on the fact that sickness depresses mood and that emotional expressions reveal inner states of individuals to others, which in turn affect approach/avoidance behaviors, we hypothesized that facial expressions of emotion may play a role in sickness detection. Using an experimental model of sickness, 22 volunteers were intravenously injected with either endotoxin (lipopolysaccharide; 2 ng/kg body weight) and placebo using a randomized cross-over design. The volunteers were two hours later asked to keep a relaxed expression on their face while their facial photograph was taken. To assess the emotional expression of the sick face, 49 participants were recruited and were asked to rate the emotional expression of the facial photographs of the volunteers when sick and when healthy. Our results indicate that the emotional expression of faces changed two hours after being made temporarily sick by an endotoxin injection. Sick faces were perceived as more sick/less healthy, but also as expressing more negative emotions, such as sadness and disgust, and less happiness and surprise. The emotional expressions mediated 59.1% of the treatment-dependent change in rated health. The inclusion of physical features associated with emotional expressions to the mediation analysis supported these results. We conclude that emotional expressions may contribute to detection and avoidance of infectious individuals and thereby be part of a behavioral defense against disease.

Identifiants

pubmed: 30953768
pii: S0889-1591(18)31165-6
doi: 10.1016/j.bbi.2019.04.003
pii:
doi:

Substances chimiques

Lipopolysaccharides 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

286-291

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Georgia Sarolidou (G)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Electronic address: georgia.sarolidou@ki.se.

John Axelsson (J)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Stress Research Institute, Stockholm University, Stockholm, Sweden; Osher Center for Integrative Medicine, Karolinska Institutet, Stockholm, Sweden.

Tina Sundelin (T)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Stress Research Institute, Stockholm University, Stockholm, Sweden; Department of Social Psychology, New York University, New York, USA.

Julie Lasselin (J)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Stress Research Institute, Stockholm University, Stockholm, Sweden.

Christina Regenbogen (C)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Institute of Neuroscience and Medicine: JARA-Institute Brain Structure Function Relationship (INM-10), Research Center Jülich, Jülich, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, Germany.

Kimmo Sorjonen (K)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Johan N Lundström (JN)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Monell Chemical Senses Center, Philadelphia, USA; Department of Psychology, University of Pennsylvania, Philadelphia, USA; Stockholm University Brain Imaging Centre, Stockholm, Sweden.

Mats Lekander (M)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Stress Research Institute, Stockholm University, Stockholm, Sweden; Osher Center for Integrative Medicine, Karolinska Institutet, Stockholm, Sweden.

Mats J Olsson (MJ)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH